EXHIBIT 10.8 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED. CONTRACT...Contract Research and Development Agreement • November 3rd, 2000 • Biomedicines Inc
Contract Type FiledNovember 3rd, 2000 Company
CONTRACT RESEARCH AND DEVELOPMENT AGREEMENT ONContract Research and Development Agreement • February 7th, 2005 • Intarcia Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledFebruary 7th, 2005 Company IndustryThis Contract Research And Development Agreement (“Agreement”) is made effective as of 17 July, 1998 (“Effective Date”), by and among BioMedicines, Inc. (“BioMedicines), a incorporated in the state of Delaware in the United States of America, having its principal business offices at 909 Marina Village Parkway No. 583, Alameda, CA 94501, and Boehringer Ingelheim Pharma KG (“BI Pharma KG”) a German corporation having a place of business at Birkendorfer Strabe 65, 88397 Biberach an der Riss, Federal Republic of Germany.